CA2579732C - Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site - Google Patents

Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site Download PDF

Info

Publication number
CA2579732C
CA2579732C CA2579732A CA2579732A CA2579732C CA 2579732 C CA2579732 C CA 2579732C CA 2579732 A CA2579732 A CA 2579732A CA 2579732 A CA2579732 A CA 2579732A CA 2579732 C CA2579732 C CA 2579732C
Authority
CA
Canada
Prior art keywords
tablet
active ingredient
release
coating
prednisone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2579732A
Other languages
English (en)
Other versions
CA2579732A1 (fr
Inventor
Achim Schaeffler
Guy Vergnault
Pascal Grenier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004043863A external-priority patent/DE102004043863A1/de
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of CA2579732A1 publication Critical patent/CA2579732A1/fr
Application granted granted Critical
Publication of CA2579732C publication Critical patent/CA2579732C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une forme posologique pharmaceutique à libération gastro-intestinale du principe actif régulée en fonction du temps et du site.
CA2579732A 2004-09-10 2005-09-09 Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site Active CA2579732C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102004043863.3 2004-09-10
DE102004043863A DE102004043863A1 (de) 2004-09-10 2004-09-10 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US11/216,469 US20060057200A1 (en) 2004-09-10 2005-09-01 Tablets with site- and time-controlled gastrointestinal release of active ingredient
US11/216,469 2005-09-01
PCT/EP2005/009726 WO2006027266A1 (fr) 2004-09-10 2005-09-09 Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site

Publications (2)

Publication Number Publication Date
CA2579732A1 CA2579732A1 (fr) 2006-03-16
CA2579732C true CA2579732C (fr) 2014-08-12

Family

ID=36036090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2579732A Active CA2579732C (fr) 2004-09-10 2005-09-09 Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site

Country Status (7)

Country Link
EP (1) EP1807058A1 (fr)
JP (1) JP5134955B2 (fr)
KR (1) KR101363563B1 (fr)
AU (1) AU2005281797B2 (fr)
CA (1) CA2579732C (fr)
NO (1) NO20071806L (fr)
WO (1) WO2006027266A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
MY149863A (en) * 2006-08-03 2013-10-31 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
AU2010207740B2 (en) 2009-01-26 2016-06-16 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
NZ745682A (en) 2012-09-26 2019-09-27 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) * 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
CN109640991A (zh) 2016-07-29 2019-04-16 詹森药业有限公司 治疗前列腺癌的方法
CN111479560A (zh) 2017-10-16 2020-07-31 阿拉贡药品公司 用于治疗非转移性去势难治性前列腺癌的抗雄激素
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2521848B2 (ja) * 1990-07-02 1996-08-07 ベーリンガー マンハイム ゲーエムベーハー 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
JP2001010950A (ja) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk 安定で良好な薬物放出を有する医薬組成物
DE10012555A1 (de) * 2000-03-15 2001-09-20 Merck Patent Gmbh Glucocorticoide in einer Modified Release-Formulierung
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
MXPA03008292A (es) * 2001-03-13 2003-12-11 Penwest Pharmaceuticals Co Formas de dosificacion cronoterapeuticas que contienen glucocorticosteroides.
JPWO2003075919A1 (ja) * 2002-03-14 2005-06-30 第一サントリーファーマ株式会社 塩酸ピルジカイニド含有錠剤（乾式）
DK1615626T3 (da) * 2003-04-24 2010-02-08 Jagotec Ag Tablet med farvet kerne
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
AU2005281797B2 (en) 2011-07-07
WO2006027266A1 (fr) 2006-03-16
NO20071806L (no) 2007-06-08
AU2005281797A1 (en) 2006-03-16
JP2008512419A (ja) 2008-04-24
EP1807058A1 (fr) 2007-07-18
CA2579732A1 (fr) 2006-03-16
JP5134955B2 (ja) 2013-01-30
KR101363563B1 (ko) 2014-02-14
KR20070098989A (ko) 2007-10-08

Similar Documents

Publication Publication Date Title
US20120213910A1 (en) Tablets with Site- and Time- Controlled Gastrointestinal Release of Active Ingredient
CA2579732C (fr) Comprimes a liberation gastro-intestinale du principe actif regulee en fonction du temps et du site
Bussemer et al. Pulsatile drug-delivery systems
US5316772A (en) Bilayered oral pharmaceutical composition with pH dependent release
US4713248A (en) Diffusion coated multiple-units dosage form
JP5671609B2 (ja) ヒドロモルホンおよびナロキソンを含む医薬組成物
US20120039954A1 (en) Method of treating insomnia
US20090181089A1 (en) PH-Controlled Pulsatile Delivery System, Methods for Preparation and Use Thereof
LV10183B (en) Oral composition for the treatment of inflammatory bowel diseases
Saigal et al. Site specific chronotherapeutic drug delivery systems: A patent review
MX2008014455A (es) Sistema de suministro de farmaco de dosis controlada.
CN110381925A (zh) 间苯三酚和三甲基间苯三酚的药物制剂
Priyanka et al. A comprehensive review on pharmaceutical mini tablets
Dressman Comparative dissolution of Budesonide from four commercially available products for oral administration: implications for interchangeablity
WO2013030726A1 (fr) Diffusion de médicament programmé
WO2007146068A2 (fr) Formulation d'alfuzosine chlorhydrate à libération contrôlée
AU2011232809B2 (en) Tablets with site and time-controlled gastrointestinal release of active ingredient
WO2009076754A1 (fr) Système thérapeutique à libération contrôlée à monocouche
PACKIARAJ FORMULATION AND EVALUATION OF CONTROLLED-RELEASE DOSAGE FORM OF CLARITHROMYCIN & PREDNISONE AS MODEL DRUGS

Legal Events

Date Code Title Description
EEER Examination request